首页> 外文期刊>Neurology Asia >Refractory status epilepticus secondary to Neurexin-3a encephalitis: A case report
【24h】

Refractory status epilepticus secondary to Neurexin-3a encephalitis: A case report

机译:Neurexin-3a脑炎继发的难治性癫痫持续状态:一例报告

获取原文
           

摘要

New–onset refractory status epilepticus (NORSE) is a rare and challenging disease entity that is associated with high morbidity and mortality. Among the NORSE cases with a proven aetiology, autoimmune encephalitis has been identified as a leading cause. Here we describe a young man who presented with NORSE and was eventually found to have serum autoantibodies against Neurexin-3a, a synaptic molecule that has recently been implicated as a target in the pathogenesis of a novel form of autoimmune encephalitis. The patient’s seizures responded to plasmapheresis, though the patient eventually died from sepsis. This case shows that Neurexin-3a encephalitis is a possible cause of NORSE, and plasmapheresis may be an effective treatment.
机译:新型难治性癫痫持续状态(NORSE)是一种罕见且具有挑战性的疾病,与高发病率和高死亡率相关。在病因得到证实的NORSE病例中,自身免疫性脑炎已被确定为主要原因。在这里,我们描述了一个年轻人,他患有NORSE,最终被发现具有针对Neurexin-3a的血清自身抗体,Neurexin-3a是一种突触分子,最近被认为是新型自身免疫性脑炎发病机制的靶标。尽管患者最终死于败血症,但患者的癫痫发作对血浆置换有所反应。该病例表明,Neurexin-3a脑炎可能是NORSE的病因,血浆置换可能是一种有效的治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号